Country Trust Bank Takes $30.72 Million Position in Xylem Inc. $XYL

Country Trust Bank bought a new position in shares of Xylem Inc. (NYSE:XYL) in the second quarter, Holdings Channel reports. The firm bought 237,447 shares of the industrial products company’s stock, valued at approximately $30,716,000.

Other institutional investors also recently modified their holdings of the company. Maseco LLP bought a new stake in shares of Xylem during the 2nd quarter worth $31,000. ST Germain D J Co. Inc. lifted its position in Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after acquiring an additional 228 shares during the last quarter. Signature Resources Capital Management LLC bought a new stake in Xylem during the second quarter valued at about $39,000. Headlands Technologies LLC boosted its holdings in Xylem by 90.6% during the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company’s stock valued at $36,000 after acquiring an additional 145 shares during the period. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of Xylem in the first quarter valued at about $40,000. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of NYSE XYL opened at $141.36 on Wednesday. The firm has a market capitalization of $34.42 billion, a price-to-earnings ratio of 36.34, a PEG ratio of 2.50 and a beta of 1.15. Xylem Inc. has a one year low of $100.47 and a one year high of $154.27. The business has a fifty day simple moving average of $146.18 and a 200 day simple moving average of $137.92. The company has a current ratio of 1.96, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.22 billion. During the same quarter in the previous year, the company earned $1.11 earnings per share. The business’s revenue was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Sell-side analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s payout ratio is presently 41.13%.

Analysts Set New Price Targets

XYL has been the subject of several recent analyst reports. Stifel Nicolaus increased their target price on Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Barclays increased their price objective on Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Mizuho set a $160.00 target price on shares of Xylem in a research report on Wednesday, October 29th. Robert W. Baird set a $178.00 target price on shares of Xylem in a research note on Wednesday, October 29th. Finally, Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $166.90.

Insider Buying and Selling

In other Xylem news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the transaction, the executive vice president owned 31,250 shares in the company, valued at $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director directly owned 16,875 shares in the company, valued at $2,499,862.50. The trade was a 9.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 13,121 shares of company stock valued at $1,982,459 over the last quarter. Corporate insiders own 0.27% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.